AMIE JONES: Open Payments
NPI 1730785247 · DERBY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 64 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $715 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $169 |
| ABBVIE INC. | 11 | $148 |
| Otsuka America Pharmaceutical, Inc. | 8 | $140 |
| Supernus Pharmaceuticals, Inc. | 4 | $109 |
| Vanda Pharmaceuticals Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Alkermes, Inc. | 2 | $50 |
| Lundbeck LLC | 2 | $46 |
Products named: REXULTI, CAPLYTA, VRAYLAR, UZEDY, Qelbree, AUSTEDO XR, Auvelity, SPRAVATO.
Industry payments across KS — which companies pay providers there.
